Teneligliptin
Sponsors
First Department of internal Medicine, Kansai Medical University, Diamond study group, Gunma University, Dokkyo Medical University, Naka Kinen Clinic
Conditions
Coronary artery diseaseDiabetes Mellitus, Type 2Healthy VolunteersType 2 Diabetes MellitusType 2 diabetesType2 Diabetes Mellitusdiabetic patients undergoing hemodialysistype 2 diabetes mellitus
Phase 1
Pharmacokinetic Drug Interaction Between Teneligliptin and Empagliflozin
CompletedNCT04431141
Start: 2020-09-15End: 2021-01-25Updated: 2021-11-15
Pharmacokinetics of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers
CompletedNCT06339788
Start: 2024-05-10End: 2024-06-12Updated: 2025-02-04
Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers
CompletedNCT06889350
Start: 2025-03-26End: 2025-05-07Updated: 2025-07-31
Phase 3
Long-term Safety Study of MP-513 in Patients With Type 2 Diabetes
CompletedNCT01301833
Start: 2011-02-28End: 2012-09-30Updated: 2026-01-02
Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic Patients
CompletedNCT02314637
Start: 2009-08-31End: 2011-07-31Updated: 2026-01-05
Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin)
CompletedNCT02354235
Start: 2015-01-31End: 2016-01-31Updated: 2026-01-07
Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin)
CompletedNCT02354222
Start: 2015-01-31End: 2016-02-29Updated: 2026-01-07
Tenelia Triple Combination Study
CompletedNCT02567994
Start: 2015-04-30End: 2017-12-31Updated: 2018-05-02
Phase 4
Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study
NCT02449330
Start: 2015-06-30End: 2023-06-30Target: 936Updated: 2018-08-22
Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)
CompletedNCT02512523
Start: 2015-08-27End: 2016-09-26Updated: 2025-01-27
Teneligliptin Versus Linagliptin in Diabetes Mellitus Type Two Patients
CompletedNCT03011177
Start: 2017-01-31End: 2018-09-30Updated: 2019-02-22
Tenelia Elderly CGMS Study(TEDDY)
CompletedNCT03508323
Start: 2018-04-03End: 2019-12-12Updated: 2022-06-30
A Randomized, Placebo-controlled Clinical Trial of Teneligliptin as Quadruple Oral Combination Therapy for Type 2 DM After Failure of an Oral Triple Anti-diabetic Regimen
CompletedNCT04446026
Start: 2020-07-08End: 2021-05-17Updated: 2021-06-09
Unknown Phase
Effects of teneligliptin for atherosclerosis-related biomarkers in patients with type 2 diabetes mellitus
Active, not recruitingJPRN-UMIN000009905
Start: 2013-02-10Target: 60Updated: 2025-07-18
Effects of teneligliptin on glycemic control and bone metabolic markers in diabetic patients undergoing hemodialysis
Active, not recruitingJPRN-UMIN000010780
Start: 2013-05-27Target: 10Updated: 2025-07-18
Effects of Teneligliptin improvement endotherial dysfunction, inflammation, coagulation and oxidative stress in patients with coronary artery disease and diabetes, pilot study(Tiramisu study).
Active, not recruitingJPRN-UMIN000011960
Start: 2013-10-05Target: 30Updated: 2025-07-18
The effects of teneligliptin on cardiac function and endothelial function in patients with type 2 diabetes
RecruitingJPRN-UMIN000012120
Start: 2013-10-28Target: 40Updated: 2025-07-18
Efficacy and safety of teneligliptin in patients with type 2 diabetes who responded insufficiently to dipeptidyl peptidase-4 (DPP-4) inhibitors
Active, not recruitingJPRN-UMIN000014298
Start: 2013-06-01Target: 20Updated: 2025-07-18
Effects of teneligliptin on serum lipid profile and insulin resistance in patients with type 2 diabetes
Active, not recruitingJPRN-UMIN000014982
Start: 2013-02-15Target: 9Updated: 2025-07-18